You are here: Industry Insights > Oxford University

News List

Oxford University’s Covid-19 vaccine shows promise in animal study pharmaceutical-technology
May 18, 2020
The University of Oxford in the UK has reported positive findings of its Covid-19 vaccine candidate in a small preclinical study involving six monkeys.
AstraZeneca, Oxford University Announce Agreement for COVID-19 Vaccine americanpharmaceuticalreview
May 07, 2020
AstraZeneca and the University of Oxford announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.
AstraZeneca and Oxford University partner on Covid-19 vaccine pharmaceutical-technology
April 30, 2020
AstraZeneca has signed an agreement with the University of Oxford to develop and distribute the university’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.
Nationwide launch for GP-based trial of COVID-19 therapies pharmatimes
April 20, 2020
As of this morning – Monday April 20 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 120,067 with 16,060 deaths.
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy b3cnewswire
March 23, 2020
Vaccitech Limited and the University of Oxford today announce initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).
Novartis and Oxford University begin R&D tie-up pharmaphorum
January 21, 2019
Novartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how patients will respond to new and existing treatments for inflammatory diseases such as multiple sclerosis (MS) and psoriasis.
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 28, 2018
J&J and Oxford University snagged $18.7 million for work on MERS, Lassa and Nipah vaccines.
Oxford Uni, Boehringer, Lilly link to test Jardiance in kidney disease pharmatimes
July 16, 2018
Boehringer Ingelheim and Eli Lilly are linking with Oxford University to assess the effect of SGLT2 inhibitor Jardiance on kidney disease and cardiovascular death.

Previous page 1 2 3 Next page